GLP-1 RAs also exert pleiotropic actions with metabolic, hepatic, renal and cardiovascular beneficial effects [4,5,6,7]
Rare but serious risks can include gallstones, pancreatitis, and surgical complications related to delayed stomach emptying
With currently approved medications like Wegovy and Mounjaro, some people stay on their current dose to maintain results, whilst others can reduce to a lower dose
For patients planning pregnancy, semaglutide should be discontinued at least 2 months before a planned pregnancy due to its long half-life
Despite the name, there is no FDA-approved GLP-1 patch containing semiglutide, tirzepatide, or any other GLP-1 receptor agonist
When the stomach and intestines do not empty properly, blockages may occur